Nyxoah SA (NYXH)

CIK 0001857190 · Healthcare · Medical Instruments & Supplies

Recent Filing Index

Form Filed Qtr End F_Period 8K: Earnings Release
Latest FY-2025 —
FY-2024 —
FY-2023 —

Filing Summary

Report Name | Notes Fiscal Period (Annual) Fiscal Period (Quarter)
Document and Entity Information
—
Statements
Consolidated Balance Sheets
—
Consolidated Statements of Loss and Other Comprehensive Loss
—
Consolidated Statements of Changes In Equity
—
Consolidated Statements of Cash Flow
—
Notes
Capital Management
—
Capital, Share Premium, Reserves
—
Cash and Cash Equivalents
—
Critical Accounting Estimates and Assumptions
—
Cybersecurity Risk Management and Strategy Disclosure
—
Employee Benefits
—
Events After The Balance-sheet Date
—
Financial Assets
—
Financial Debt
—
Financial Expense
—
Financial Income
—
General Information
—
Income Taxes and Deferred Taxes
—
Insider Trading Policies and Procedures
—
Intangible Assets
—
Inventory
—
Loss Per Share (eps)
—
Management of Financial Risks
—
Material Accounting Policies
—
Operating Expenses
—
Other Commitments
—
Other Current Assets
—
Other Liabilities
—
Other Long-term Receivables
—
Other Operating Income and Expenses
—
Other Payables
—
Pension Schemes
—
Property, Plant and Equipment
—
Provisions
—
Related Parties
—
Related Party Transactions
—
Research and Development Expenses
—
Revenue and Cost of Goods Sold
—
Right of Use Assets and Lease Liabilities
—
Selling, General and Administrative Expenses
—
Share Capital, Share Premium, Reserves
—
Share-based Compensation
—
Subsidiaries
—
Trade and Other Receivables
—
Trade Payables
—
Trade Receivables, Contract Assets and Other Receivables
—